Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Berger

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Heart Failure|February 5, 2009
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatientsChristopher Adlbrecht, Martin Hülsmann, Guido Strunk, et al.
European Journal of Internal Medicine|March 19, 2020
Impact of treatment strategies on long-term outcome of CTO patientsChristian Roth, Georg Goliasch, Stefan Aschauer, et al.
Journal of the American Heart Association|January 12, 2024
Association of Periprocedural Inflammatory Activation With Increased Risk for Early Coronary Stent ThrombosisKonstantin A Krychtiuk, Konstantin Bräu, Stephanie Schauer, et al.
International Journal of Cardiology|December 11, 2012
A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failureBernhard Richter, Lorenz Koller, Philipp J Hohensinner, et al.
European Heart Journal|February 15, 2007
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchronyFriedrich M Fruhwald, Astrid Fahrleitner-Pammer, Rudolf Berger, et al.
Atherosclerosis|September 17, 2010
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failureBernhard Richter, Kathrin Rychli, Philipp J Hohensinner, et al.
Journal of Clinical Lipidology|April 11, 2017
Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failureLorenz Koller, Bernhard Richter, Max-Paul Winter, et al.
European Heart Journal|August 15, 2008
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volumeChristopher Adlbrecht, Spyridoula Kommata, Martin Hülsmann, et al.
International Journal of Cardiology|November 29, 2024
Association of ABO blood group with risk of coronary stent thrombosisCaglayan Demirel, Kevin Hamzaraj, Janina Fangl, et al.
Heart (British Cardiac Society)|May 17, 2011
Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failureKathrin Rychli, Bernhard Richter, Philipp J Hohensinner, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Heart Failure|February 5, 2009
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatientsChristopher Adlbrecht, Martin Hülsmann, Guido Strunk, et al.
European Journal of Internal Medicine|March 19, 2020
Impact of treatment strategies on long-term outcome of CTO patientsChristian Roth, Georg Goliasch, Stefan Aschauer, et al.
Journal of the American Heart Association|January 12, 2024
Association of Periprocedural Inflammatory Activation With Increased Risk for Early Coronary Stent ThrombosisKonstantin A Krychtiuk, Konstantin Bräu, Stephanie Schauer, et al.
International Journal of Cardiology|December 11, 2012
A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failureBernhard Richter, Lorenz Koller, Philipp J Hohensinner, et al.
European Heart Journal|February 15, 2007
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchronyFriedrich M Fruhwald, Astrid Fahrleitner-Pammer, Rudolf Berger, et al.
Atherosclerosis|September 17, 2010
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failureBernhard Richter, Kathrin Rychli, Philipp J Hohensinner, et al.
Journal of Clinical Lipidology|April 11, 2017
Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failureLorenz Koller, Bernhard Richter, Max-Paul Winter, et al.
European Heart Journal|August 15, 2008
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volumeChristopher Adlbrecht, Spyridoula Kommata, Martin Hülsmann, et al.
International Journal of Cardiology|November 29, 2024
Association of ABO blood group with risk of coronary stent thrombosisCaglayan Demirel, Kevin Hamzaraj, Janina Fangl, et al.
Heart (British Cardiac Society)|May 17, 2011
Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failureKathrin Rychli, Bernhard Richter, Philipp J Hohensinner, et al.
Pageof 8